NIH and Fogarty stand against structural racism in biomedical research
March / April 2021 | Volume 20 Number 2
Opinion by Fogarty Director Dr Roger I Glass
I applaud NIH Director Dr. Francis S. Collins on the strong stance he is taking to
eliminate structural racism at NIH and throughout the biomedical research community.
We at Fogarty
join him in condemning racism and bigotry in all its forms and remain committed to our mission to work toward achieving equity for all the world’s people. While the NIH has long supported programs to improve the diversity of the scientific workforce, those efforts have not been sufficient to achieve racial equity across the biomedical research enterprise. We’re committed to identifying and dismantling any policies and practices that may harm our workforce and our science. To begin this critical work, NIH has launched a new program called UNITE.
UNITE has five components with the following specific aims:
- U - Understanding stakeholder experiences through listening and learning
- N - New research on health disparities, minority health and health equity
- I - Improving the NIH culture and structure for equity, inclusion and excellence
- T - Transparency, communication and accountability with our internal and external stakeholders
- E - Extramural research ecosystem: changing policy, culture and structure to promote workforce diversity
The UNITE initiative was established to identify and address structural racism within the NIH-supported and the greater scientific community. With representation from across NIH, UNITE aims to establish an equitable and civil culture within the biomedical research enterprise and reduce barriers to racial equity in the biomedical research workforce. To reach this goal, UNITE is facilitating research to identify opportunities, make recommendations, and develop and implement strategies to increase inclusivity and diversity in science. These efforts will bolster the NIH’s effort to continue to strive for diversity within the scientific workforce and racial equity on the NIH campus and within the extramural community.
The COVID-19 pandemic has heightened awareness of the deeply ingrained inequities, racist violence and bigotry that continue to exist in our society. This was brought home to me recently with the tragic shooting of Asian-Americans in Atlanta, the city where I live. It is painful to me that many of my longtime research colleagues of Asian descent are experiencing unpleasant acts of bigotry and discrimination. I am distressed that some of them and their families now feel unsafe and unwelcome in the country they have called home for decades, where they have worked tirelessly to make scientific contributions that improve health for all people.
The Atlanta violence spurred the White House to issue a statement
condemning acts of discrimination, bullying, harassment and hate crimes directed toward Asian American and Pacific Islander (AAPI) communities. NIH Director Dr. Francis S. Collins pointed out recently that the COVID-19 vaccines we have today were made possible by the rapid public disclosure by Chinese researchers of the novel coronavirus’s genetic sequence. Science continues to be a global effort, he added, and we are all in this together.
This is an opportunity for all of us to reflect on what more we can do to address these continuing problems, to determine how we can contribute to meaningful solutions - individually and through our collective efforts - so that one day all people will live in a just and equitable world. We must channel our outrage, grief and frustration into positive change.
For us in the global health community, we are also considering how we can work together with our grantees and collaborators to
decolonize and democratize global health research. Both remain complex and challenging barriers to health equity.
Identifying and dismantling racist components of a system that has been hundreds of years in the making is no easy task and this is just the beginning. I call on all in the Fogarty community to join us in our quest for peace, equality and social justice, here at home, as well as around the globe. The continuing issues of social justice, the importance of diversity, alongside the racism and police brutality that persist in our society have again come to the fore and been heightened by the COVID-19 pandemic, which has impacted minorities and vulnerable groups far more than others.
NIH: Ending Structural Racism
NIH Unite Initiative
Racism and Health from U.S. Centers for Disease Control and Prevention (CDC)
- NIH names Dr Marie A Bernard as Chief Officer for Scientific Workforce Diversity
NIH news, May 26, 2021
NIH stands against structural racism in biomedical research
Statement by NIH Director Dr Francis S. Collins
NIH news, March 1, 2021
Memorandum condemning and combating racism, xenophobia and intolerance against Asian Americans and Pacific Islanders in the United States
The White House, January 26, 2021
Request for Information (RFI): Inviting Comments and Suggestions to Advance and Strengthen Racial Equity, Diversity, and Inclusion in the Biomedical Research Workforce and Advance Health Disparities and Health Equity Research (NOT-OD-21-066)
Submit responses by April 9, 2021.
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (NOT-MD-21-016)
Estimated publication date: April 9, 2021
First estimated application due date: August 20, 2021
- NIH Common Fund funding opportunities:
Transformative Research to Address Health Disparities and Advance Health Equity
Application due date: May 28, 2021
Opinion: Together, we must work to end racism and promote equality through global health research and training
May / June 2020
Global Health Matters
Opinion: Decolonizing and democratizing global health are difficult, but vital goals
July / August 2020
Global Health Matters
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.